The present invention pertains to medical devices and methods for manufacturing medical devices. More particularly, the present invention pertains to manufacturing medical devices at least in part from linear elastic materials.
A vast number of medical devices are available for the treatment of numerous ailments. Each of the different types of devices have certain uses, characteristics, and features. Often the features of a particular device can be derived from the materials used to manufacture the device. For example, a manufacturer may choose to construct a catheter at least partially from flexible materials so that the catheter can bend when navigating the vasculature. The type of flexible material used for making this flexible catheter may further vary depending on the amount of flexibility desired and the practicability of working with the material. Because of the variability among materials, each particular material may have certain advantages and disadvantages. There is an ongoing need for further improvements and refinements to medical devices including improvements regarding the selection of materials and methods used for manufacturing them.
The present invention pertains to medical devices that are at least partially manufactured from linear elastic materials. Additionally, the present invention also pertains to methods for manufacturing medical devices from linear elastic materials. These methods may include, for example, cold-forming and/or low-temperature heat setting. Some examples of these medical devices and methods of manufacturing medical devices are described in more detail below.
The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings illustrate example embodiments of the claimed invention.
Shape-memory and super elastic materials, including nickel-titanium alloys such as nitinol, have numerous applications throughout the medical device and other industries. The numerous applications may be due to the shape-memory and super elastic properties of these materials, which may be desirable. The desirable properties of super elastic and shape-memory materials are generally not native to the commercially available or “bulk” materials and, instead, need to be imparted by subjecting them to a number of processing steps. For example, the processing steps may include heat treatment, cold working, and/or other processing steps. In some instances, these processing steps may be sophisticated or complicated.
Some varieties of super elastic materials, for example nitinol alloys, may be commercially available or otherwise can be processed to be “linear elastic”. The linear elastic versions of nitinol are similar in chemistry to conventional shape memory and super elastic varieties and may exhibit distinct and useful mechanical properties. For example, linear elastic nitinol does not display a “super elastic plateau” or “flag region” in its stress/strain curve, which are indicative of super elastic nitinol. Instead, as recoverable strain increases, the stress continues to increase in an essentially linear relationship until plastic deformation begins. In some embodiments, the linear elastic nickel-titanium alloy is an alloy that does not show any martensite/austenite phase changes that are detectable by DSC and DMTA analysis over a large temperature range. For example, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −150° C. to about 400° C.
In addition to linear elastic nitinol, a number of other linear elastic or “super elastic precursor” materials are also known and may be available. Some examples of these materials include silver-cadmium alloy, gold-cadmium alloy, gold-copper-zinc alloy, copper-zinc alloy, copper-zinc-aluminum alloy, copper-zinc-tin alloy, iron-beryllium alloy, iron-platinum alloy, indium-thallium alloy, iron-manganese alloy, nickel-titanium-vanadium alloy, iron-nickel-titanium-cobalt alloy, copper-tin alloy, nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, or the like, or other suitable material.
In general, filter 14 may be adapted to operate between a first generally collapsed configuration and a second generally expanded configuration for collecting debris in a body lumen. In some embodiments, filter 14 can be delivered to an appropriate intravascular location, for example “downstream” of an intravascular lesion, using an appropriate filter delivery device. Similarly, filter 14 can be removed from the vasculature at the desired time by an appropriate filter retrieval device.
In at least some embodiments, frame assembly 18 may be at least partially manufactured from linear elastic materials. For example, the portion of frame assembly 18 defining filter loop 20 may be manufactured from linear elastic materials. However, any portion or all of frame assembly 18 may include a linear elastic material. Additionally, other portions of device 10 including shaft 12 may include linear elastic materials. In some embodiments, the linear elastic material may be a nickel-titanium alloy such as linear elastic nitinol. One example of a suitable linear elastic nitinol is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. It can be appreciated, however, that any of the other materials described herein, or any other appropriate linear elastic or super elastic precursor material may be used.
The manufacturing of device 10 may generally include disposing the linear elastic material, including those linear elastic materials described herein, about a filter forming member 26 to define frame assembly 18 as shown in
In some embodiments, disposing the linear elastic material on forming member 26 to define frame assembly 18 may include cold-forming or room temperature shape setting. In general, cold-forming is understood to be forming, bending, shaping, or otherwise altering the shape of the linear elastic material to define frame assembly 18 without substantially increasing temperature or changing the thermal conditions. For example, cold-forming may occur at temperatures near the ambient room temperature such as about 15–25 degrees Celsius. Although some materials such as linear elastic nitinol may have a tendency to crack when highly deformed, this was, unexpectedly, not found to be the case.
The cold-formed linear elastic nitinol, after disposing it on forming member 26, somewhat unexpectedly can retain the set shape corresponding to the shape of frame assembly 18. However, a certain amount of “spring-back” may be observed. Spring-back is understood to be the tendency of the cold-formed linear elastic material to partially spring back or enlarge to a size that is slightly larger than the size that would otherwise be defined by shaping member 26. The amount of spring-back may vary depending on the material used, amount of thermal energy added (if any), and other factors. However, the amount of spring-back has been found to be substantially consistent among consistent manufacturing conditions. Thus, a manufacturer can reproducibly predict the expected amount of spring-back for essentially any given set of materials and/or thermal conditions.
Because of spring-back, some example manufacturing methods may include manufacturing frame assembly 18 by disposing a linear elastic material on a forming member 26 that is reduced in size. For example, the reduced size forming member 26 may be about 1.25–3 times smaller (i.e., about ⅓ to ⅘ the size of a forming member that might be used in the absence of spring-back). More particularly, forming member 26 may be sized to define a reduced size or “pre spring-back” frame assembly 18 that is about 1.25–3 times smaller than the desired final size for frame assembly 18. After forming the reduced size frame assembly 18, it can spring-back or enlarge to the desired full or final size frame assembly 18. Moreover, given the reproducibility of spring-back, a manufacturer can vary the size of forming member 26 and the thermal conditions to produce frame assemblies in a wide variety of sizes.
In some embodiments, the cold-formed frame assembly 18 may be coupled to filter membrane 24 in any appropriate manner (e.g., dip-molding, spray molding, thermal or adhesive bonding, and the like), as shown in
In some other embodiments, frame assembly 18 can be manufactured using low-temperature heat setting. According to this embodiment, the linear elastic material can be can be disposed on forming member 26 to define frame assembly 18 (as shown in
It is believed that low-temperature heat setting results in the material being substantially set to the desired shape, but results in the material having or maintaining linear elastic properties instead of acquiring super elastic properties. For example,
Although the above discussion describes some the manufacturing methods for constructing filtering devices at least partially from linear elastic materials, this is not intended to be limited to just filtering devices. It can be appreciated that a number of other medical devices may be similarly manufactured from linear elastic materials according the manufacturing methods described herein. For example, some of the other types of medical devices may include electro-physiology baskets, stents, stent connectors, guidewire coils and couplers, vena cava filters, snares, stiffening wires and mandrels for catheters, support coils or ribbons for catheters, bone anchors, orthodontic wires and devices, curved needles and other direct injection drug delivery devices, electrodes, heart valves, distal protection filters and filter baskets, and the like.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Number | Name | Date | Kind |
---|---|---|---|
3472230 | Fogarty | Oct 1969 | A |
3952747 | Kimmell, Jr. | Apr 1976 | A |
3996938 | Clark, III | Dec 1976 | A |
4046150 | Schwartz et al. | Sep 1977 | A |
4425908 | Simon | Jan 1984 | A |
4590938 | Segura et al. | May 1986 | A |
4619246 | Molgaard-Nielsen et al. | Oct 1986 | A |
4650466 | Luther | Mar 1987 | A |
4706671 | Weinrib | Nov 1987 | A |
4723549 | Wholey et al. | Feb 1988 | A |
4790812 | Hawkins, Jr. et al. | Dec 1988 | A |
4790813 | Kensey | Dec 1988 | A |
4794928 | Kletschka | Jan 1989 | A |
4807626 | McGirr | Feb 1989 | A |
4842579 | Shiber | Jun 1989 | A |
4873978 | Ginsburg | Oct 1989 | A |
4886061 | Fischell et al. | Dec 1989 | A |
4921478 | Solano et al. | May 1990 | A |
4921484 | Hillstead | May 1990 | A |
4926858 | Gifford, III et al. | May 1990 | A |
4969891 | Gewertz | Nov 1990 | A |
4998539 | Delsanti | Mar 1991 | A |
5002560 | Machold et al. | Mar 1991 | A |
5011488 | Ginsburg | Apr 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5057114 | Wittich et al. | Oct 1991 | A |
5067957 | Jervis | Nov 1991 | A |
5069226 | Yamauchi et al. | Dec 1991 | A |
5071407 | Termin et al. | Dec 1991 | A |
5100423 | Fearnot | Mar 1992 | A |
5102415 | Guenther et al. | Apr 1992 | A |
5133733 | Rasmussen et al. | Jul 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5152777 | Goldberg et al. | Oct 1992 | A |
5160342 | Reger et al. | Nov 1992 | A |
5197978 | Hess | Mar 1993 | A |
5224953 | Morgentaler | Jul 1993 | A |
5230348 | Ishibe et al. | Jul 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5329942 | Gunther et al. | Jul 1994 | A |
5330484 | Gunther | Jul 1994 | A |
5354310 | Garnie et al. | Oct 1994 | A |
5376100 | Lefebvre | Dec 1994 | A |
5411476 | Abrams et al. | May 1995 | A |
5421832 | Lefebvre | Jun 1995 | A |
5423742 | Theron | Jun 1995 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5456667 | Ham et al. | Oct 1995 | A |
5462529 | Simpson et al. | Oct 1995 | A |
5536242 | Willard et al. | Jul 1996 | A |
5549626 | Miller et al. | Aug 1996 | A |
5597378 | Jervis | Jan 1997 | A |
5637089 | Abrams et al. | Jun 1997 | A |
5658296 | Bates et al. | Aug 1997 | A |
5662671 | Barbut et al. | Sep 1997 | A |
5695519 | Summers et al. | Dec 1997 | A |
5720764 | Naderlinger | Feb 1998 | A |
5728066 | Daneshvar | Mar 1998 | A |
5749848 | Jang et al. | May 1998 | A |
5769796 | Palermo et al. | Jun 1998 | A |
5769816 | Barbut et al. | Jun 1998 | A |
5776162 | Kleshinski | Jul 1998 | A |
5779716 | Cano et al. | Jul 1998 | A |
5792157 | Mische et al. | Aug 1998 | A |
5795322 | Boudewijn | Aug 1998 | A |
5800457 | Gelbfish | Sep 1998 | A |
5800525 | Bachinski et al. | Sep 1998 | A |
5807398 | Shaknovich | Sep 1998 | A |
5810874 | Lefebvre | Sep 1998 | A |
5814064 | Daniel et al. | Sep 1998 | A |
5827324 | Cassell et al. | Oct 1998 | A |
5833644 | Zadno-Azizi et al. | Nov 1998 | A |
5833650 | Imran | Nov 1998 | A |
5836969 | Kim et al. | Nov 1998 | A |
5843244 | Pelton et al. | Dec 1998 | A |
5846247 | Unsworth et al. | Dec 1998 | A |
5846260 | Maahs | Dec 1998 | A |
5848964 | Samuels | Dec 1998 | A |
5876367 | Kaganov et al. | Mar 1999 | A |
5895399 | Barbut et al. | Apr 1999 | A |
5902317 | Kleshinski et al. | May 1999 | A |
5910154 | Tsugita et al. | Jun 1999 | A |
5911734 | Tsugita et al. | Jun 1999 | A |
5925016 | Chornenky et al. | Jul 1999 | A |
5925060 | Forber | Jul 1999 | A |
5925062 | Purdy | Jul 1999 | A |
5935139 | Bates | Aug 1999 | A |
5941869 | Patterson et al. | Aug 1999 | A |
5941896 | Kerr | Aug 1999 | A |
5947995 | Samuels | Sep 1999 | A |
5951793 | Mitose et al. | Sep 1999 | A |
5954745 | Gertler et al. | Sep 1999 | A |
5980555 | Barbut et al. | Nov 1999 | A |
5989281 | Barbut et al. | Nov 1999 | A |
5993469 | McKenzie et al. | Nov 1999 | A |
5997557 | Barbut et al. | Dec 1999 | A |
6001118 | Daniel et al. | Dec 1999 | A |
6007557 | Ambrisco et al. | Dec 1999 | A |
6010522 | Barbut et al. | Jan 2000 | A |
6013085 | Howard | Jan 2000 | A |
6027520 | Tsugita et al. | Feb 2000 | A |
RE36628 | Sagae et al. | Mar 2000 | E |
6042553 | Solar et al. | Mar 2000 | A |
6042598 | Tsugita et al. | Mar 2000 | A |
6051014 | Jang | Apr 2000 | A |
6051015 | Maahs | Apr 2000 | A |
6053932 | Daniel et al. | Apr 2000 | A |
6059814 | Ladd | May 2000 | A |
6066149 | Samson et al. | May 2000 | A |
6066158 | Engelson et al. | May 2000 | A |
6068645 | Tu | May 2000 | A |
6086605 | Barbut et al. | Jul 2000 | A |
6096053 | Bates | Aug 2000 | A |
6117154 | Barbut et al. | Sep 2000 | A |
6117157 | Tekulve | Sep 2000 | A |
6129739 | Khosravi | Oct 2000 | A |
6136016 | Barbut et al. | Oct 2000 | A |
6142987 | Tsugita | Nov 2000 | A |
6152946 | Broome et al. | Nov 2000 | A |
6165200 | Tsugita et al. | Dec 2000 | A |
6168571 | Solar et al. | Jan 2001 | B1 |
6168579 | Tsugita | Jan 2001 | B1 |
6171327 | Daniel et al. | Jan 2001 | B1 |
6171328 | Addis | Jan 2001 | B1 |
6179851 | Barbut et al. | Jan 2001 | B1 |
6179859 | Bates et al. | Jan 2001 | B1 |
6179861 | Khosravi et al. | Jan 2001 | B1 |
6203561 | Ramee et al. | Mar 2001 | B1 |
6206868 | Parodi | Mar 2001 | B1 |
6214026 | Lepak et al. | Apr 2001 | B1 |
6217589 | McAlister | Apr 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6224620 | Maahs | May 2001 | B1 |
6231544 | Tsugita et al. | May 2001 | B1 |
6235044 | Root et al. | May 2001 | B1 |
6235045 | Barbut et al. | May 2001 | B1 |
6238412 | Dubrul et al. | May 2001 | B1 |
6245087 | Addis | Jun 2001 | B1 |
6245088 | Lowery | Jun 2001 | B1 |
6245089 | Daniel et al. | Jun 2001 | B1 |
6258115 | Dubrul | Jul 2001 | B1 |
6264663 | Cano | Jul 2001 | B1 |
6264672 | Fisher | Jul 2001 | B1 |
6270513 | Tsugita et al. | Aug 2001 | B1 |
6273900 | Nott et al. | Aug 2001 | B1 |
6277138 | Levinson et al. | Aug 2001 | B1 |
6277139 | Levinson et al. | Aug 2001 | B1 |
6280413 | Clark et al. | Aug 2001 | B1 |
6280539 | Abrams et al. | Aug 2001 | B1 |
6287321 | Jang | Sep 2001 | B1 |
6290710 | Cryer et al. | Sep 2001 | B1 |
6309399 | Barbut et al. | Oct 2001 | B1 |
6319268 | Ambrisco et al. | Nov 2001 | B1 |
6344049 | Levinson et al. | Feb 2002 | B1 |
6346116 | Brooks et al. | Feb 2002 | B1 |
6375670 | Greenhalgh | Apr 2002 | B1 |
6402761 | McAlister | Jun 2002 | B1 |
6428559 | Johnson | Aug 2002 | B1 |
6461370 | Gray et al. | Oct 2002 | B1 |
6461453 | Abrams et al. | Oct 2002 | B1 |
6482222 | Bruckheimer et al. | Nov 2002 | B1 |
6485507 | Walak et al. | Nov 2002 | B1 |
6511496 | Huter et al. | Jan 2003 | B1 |
6517559 | O'Connell | Feb 2003 | B1 |
6520987 | Plante | Feb 2003 | B1 |
6726703 | Broome et al. | Apr 2004 | B1 |
6939362 | Boyle et al. | Sep 2005 | B1 |
20020193824 | Boylan et al. | Dec 2002 | A1 |
Number | Date | Country |
---|---|---|
28 21 048 | Jul 1980 | DE |
34 17 738 | Nov 1985 | DE |
40 30 998 | Oct 1990 | DE |
199 16 162 | Oct 2000 | DE |
0 200 688 | Nov 1986 | EP |
0 293 605 | Dec 1988 | EP |
0 411 118 | Feb 1991 | EP |
0 427 429 | May 1991 | EP |
0 437 121 | Jul 1991 | EP |
0 472 334 | Feb 1992 | EP |
0 472 368 | Feb 1992 | EP |
0 533 511 | Mar 1993 | EP |
0 655 228 | Nov 1994 | EP |
0 686 379 | Jun 1995 | EP |
0 696 447 | Feb 1996 | EP |
0 737 450 | Oct 1996 | EP |
0 743 046 | Nov 1996 | EP |
0 759 287 | Feb 1997 | EP |
0 771 549 | May 1997 | EP |
0 784 988 | Jul 1997 | EP |
0 812 928 | Dec 1997 | EP |
0 852 132 | Jul 1998 | EP |
0 873 734 | Oct 1998 | EP |
1 127 556 | Aug 2001 | EP |
1 142 604 | Oct 2001 | EP |
2 580 504 | Oct 1986 | FR |
2 643 250 | Aug 1990 | FR |
2 666 980 | Mar 1992 | FR |
2 694 687 | Aug 1992 | FR |
2 768 326 | Mar 1999 | FR |
2 020 557 | Jan 1983 | GB |
8-187294 | Jul 1996 | JP |
764684 | Sep 1980 | SU |
WO 8809683 | Dec 1988 | WO |
WO 9203097 | Mar 1992 | WO |
WO 9414389 | Jul 1994 | WO |
WO 9424946 | Nov 1994 | WO |
WO 9601591 | Jan 1996 | WO |
WO 9610375 | Apr 1996 | WO |
WO 9619941 | Jul 1996 | WO |
WO 9623441 | Aug 1996 | WO |
WO 9633677 | Oct 1996 | WO |
WO 9717100 | May 1997 | WO |
WO 9727808 | Aug 1997 | WO |
WO 9742879 | Nov 1997 | WO |
WO 9802084 | Jan 1998 | WO |
WO 9802112 | Jan 1998 | WO |
WO 9823322 | Jun 1998 | WO |
WO 9833443 | Aug 1998 | WO |
WO 9834673 | Aug 1998 | WO |
WO 9836786 | Aug 1998 | WO |
WO 9838920 | Sep 1998 | WO |
WO 9838929 | Sep 1998 | WO |
WO 9839046 | Sep 1998 | WO |
WO 9839053 | Sep 1998 | WO |
WO 9846297 | Oct 1998 | WO |
WO 9847447 | Oct 1998 | WO |
WO 9849952 | Nov 1998 | WO |
WO 9850103 | Nov 1998 | WO |
WO 9851237 | Nov 1998 | WO |
WO 9855175 | Dec 1998 | WO |
WO 9909895 | Mar 1999 | WO |
WO 9922673 | May 1999 | WO |
WO 9923976 | May 1999 | WO |
WO 9925252 | May 1999 | WO |
WO 9930766 | Jun 1999 | WO |
0 934 729 | Aug 1999 | WO |
WO 9940964 | Aug 1999 | WO |
WO 9942059 | Aug 1999 | WO |
WO 9944510 | Sep 1999 | WO |
WO 9944542 | Sep 1999 | WO |
WO 9955236 | Nov 1999 | WO |
WO 9958068 | Nov 1999 | WO |
WO 0007521 | Feb 2000 | WO |
WO 0007655 | Feb 2000 | WO |
WO 0009054 | Feb 2000 | WO |
WO 0016705 | Mar 2000 | WO |
WO 0049970 | Aug 2000 | WO |
WO 0053120 | Sep 2000 | WO |
WO 0067664 | Nov 2000 | WO |
WO 0067665 | Nov 2000 | WO |
WO 0067666 | Nov 2000 | WO |
WO 0067668 | Nov 2000 | WO |
WO 0067669 | Nov 2000 | WO |
WO 0105462 | Jan 2001 | WO |
WO 0108595 | Feb 2001 | WO |
WO 0108596 | Feb 2001 | WO |
WO 0108742 | Feb 2001 | WO |
WO 0108743 | Feb 2001 | WO |
WO 0110320 | Feb 2001 | WO |
WO 0115629 | Mar 2001 | WO |
WO 0121077 | Mar 2001 | WO |
WO 0121100 | Mar 2001 | WO |
WO 0126726 | Apr 2001 | WO |
WO 0135857 | May 2001 | WO |
WO 0143662 | Jun 2001 | WO |
WO 0147579 | Jul 2001 | WO |
WO 0149208 | Jul 2001 | WO |
WO 0149209 | Jul 2001 | WO |
WO 0149215 | Jul 2001 | WO |
WO 0149355 | Jul 2001 | WO |
WO 0152768 | Jul 2001 | WO |
WO 0158382 | Aug 2001 | WO |
WO 0160442 | Aug 2001 | WO |
WO 0167989 | Sep 2001 | WO |
WO 0170326 | Sep 2001 | WO |
WO 0172205 | Oct 2001 | WO |
WO 0187183 | Nov 2001 | WO |
WO 0189413 | Nov 2001 | WO |
WO 0191824 | Dec 2001 | WO |
WO 02094111 | Nov 2002 | WO |
Number | Date | Country | |
---|---|---|---|
20040193207 A1 | Sep 2004 | US |